Annual Interest Expense
$75.60 M
+$72.80 M+2599.89%
31 December 2023
Summary:
Ionis Pharmaceuticals annual interest expense is currently $75.60 million, with the most recent change of +$72.80 million (+2599.89%) on 31 December 2023. During the last 3 years, it has risen by +$69.40 million (+1119.31%). IONS annual interest expense is now at all-time high.IONS Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$21.23 M
-$1.55 M-6.82%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly interest expense is currently $21.23 million, with the most recent change of -$1.55 million (-6.82%) on 30 September 2024. Over the past year, it has increased by +$854.00 thousand (+4.19%). IONS quarterly interest expense is now -6.82% below its all-time high of $22.79 million, reached on 30 June 2024.IONS Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$85.43 M
+$854.00 K+1.01%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM interest expense is currently $85.43 million, with the most recent change of +$854.00 thousand (+1.01%) on 30 September 2024. Over the past year, it has increased by +$28.88 million (+51.07%). IONS TTM interest expense is now at all-time high.IONS TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2599.9% | +4.2% | +51.1% |
| 3 y3 years | +1119.3% | +2259.2% | +3284.6% |
| 5 y5 years | +68.8% | +76.9% | +82.3% |
IONS Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2599.9% | -6.8% | +5208.3% | at high | +3284.6% |
| 5 y | 5 years | at high | +2599.9% | -6.8% | +192.5% | at high | +614.8% |
| alltime | all time | at high | +2599.9% | -6.8% | +192.5% | at high | +614.8% |
Ionis Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $21.23 M(-6.8%) | $85.43 M(+1.0%) |
| June 2024 | - | $22.79 M(+10.8%) | $84.57 M(+3.5%) |
| Mar 2024 | - | $20.56 M(-1.4%) | $81.73 M(+6.2%) |
| Dec 2023 | $75.60 M(+2599.9%) | $20.85 M(+2.3%) | $77.00 M(+36.2%) |
| Sept 2023 | - | $20.38 M(+2.2%) | $56.55 M(+53.0%) |
| June 2023 | - | $19.95 M(+26.1%) | $36.97 M(+107.4%) |
| Mar 2023 | - | $15.82 M(+3855.7%) | $17.82 M(+531.6%) |
| Dec 2022 | $2.80 M(-36.4%) | $400.00 K(-50.0%) | $2.82 M(-12.4%) |
| Sept 2022 | - | $800.00 K(0.0%) | $3.22 M(-3.0%) |
| June 2022 | - | $800.00 K(-2.7%) | $3.32 M(-5.7%) |
| Mar 2022 | - | $822.00 K(+2.8%) | $3.52 M(-16.1%) |
| Dec 2021 | $4.40 M(-29.0%) | $800.00 K(-11.1%) | $4.20 M(+66.4%) |
| Sept 2021 | - | $900.00 K(-10.0%) | $2.52 M(-37.7%) |
| June 2021 | - | $1.00 M(-33.3%) | $4.05 M(-26.2%) |
| Mar 2021 | - | $1.50 M(-271.2%) | $5.49 M(0.0%) |
| Dec 2020 | $6.20 M(-50.2%) | -$876.00 K(-136.1%) | $5.49 M(-133.1%) |
| Sept 2020 | - | $2.43 M(-0.5%) | -$16.59 M(+136.4%) |
| June 2020 | - | $2.44 M(+62.7%) | -$7.02 M(-400.0%) |
| Mar 2020 | - | $1.50 M(-106.5%) | $2.34 M(-81.2%) |
| Dec 2019 | $12.44 M(-72.2%) | -$22.96 M(-291.3%) | $12.44 M(-73.5%) |
| Sept 2019 | - | $12.00 M(+1.7%) | $46.86 M(+1.6%) |
| June 2019 | - | $11.80 M(+1.8%) | $46.14 M(+1.5%) |
| Mar 2019 | - | $11.60 M(+1.2%) | $45.45 M(+1.5%) |
| Dec 2018 | $44.79 M(+0.1%) | $11.46 M(+1.6%) | $44.79 M(+1.5%) |
| Sept 2018 | - | $11.28 M(+1.5%) | $44.12 M(+1.0%) |
| June 2018 | - | $11.11 M(+1.6%) | $43.66 M(-1.5%) |
| Mar 2018 | - | $10.94 M(+1.4%) | $44.33 M(-0.9%) |
| Dec 2017 | $44.75 M(+15.4%) | $10.79 M(-0.4%) | $44.75 M(+1.9%) |
| Sept 2017 | - | $10.82 M(-8.1%) | $43.90 M(+2.5%) |
| June 2017 | - | $11.78 M(+3.7%) | $42.82 M(+5.3%) |
| Mar 2017 | - | $11.36 M(+14.4%) | $40.67 M(+4.8%) |
| Dec 2016 | $38.80 M | $9.93 M(+1.9%) | $38.80 M(+1.5%) |
| Sept 2016 | - | $9.75 M(+1.3%) | $38.21 M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $9.63 M(+1.4%) | $37.70 M(+1.3%) |
| Mar 2016 | - | $9.49 M(+1.5%) | $37.20 M(+1.3%) |
| Dec 2015 | $36.73 M(+65.4%) | $9.35 M(+1.3%) | $36.73 M(+5.9%) |
| Sept 2015 | - | $9.23 M(+1.2%) | $34.69 M(+13.9%) |
| June 2015 | - | $9.13 M(+1.2%) | $30.45 M(+15.8%) |
| Mar 2015 | - | $9.02 M(+23.5%) | $26.29 M(+18.4%) |
| Dec 2014 | $22.21 M(+14.7%) | $7.31 M(+46.2%) | $22.21 M(+12.2%) |
| Sept 2014 | - | $5.00 M(+0.7%) | $19.79 M(+0.7%) |
| June 2014 | - | $4.96 M(+0.4%) | $19.66 M(+0.8%) |
| Mar 2014 | - | $4.94 M(+1.2%) | $19.50 M(+0.8%) |
| Dec 2013 | $19.36 M(-8.5%) | $4.88 M(+0.4%) | $19.36 M(+0.4%) |
| Sept 2013 | - | $4.87 M(+1.2%) | $19.29 M(-5.3%) |
| June 2013 | - | $4.81 M(+0.3%) | $20.36 M(-2.0%) |
| Mar 2013 | - | $4.79 M(-0.5%) | $20.77 M(-1.8%) |
| Dec 2012 | $21.15 M(+26.4%) | $4.82 M(-18.9%) | $21.15 M(-1.4%) |
| Sept 2012 | - | $5.94 M(+13.8%) | $21.44 M(+5.7%) |
| June 2012 | - | $5.22 M(+0.8%) | $20.28 M(+9.6%) |
| Mar 2012 | - | $5.18 M(+1.4%) | $18.50 M(+10.5%) |
| Dec 2011 | $16.73 M(+26.5%) | $5.11 M(+7.0%) | $16.73 M(+11.4%) |
| Sept 2011 | - | $4.77 M(+38.9%) | $15.02 M(+10.6%) |
| June 2011 | - | $3.44 M(+0.6%) | $13.59 M(+1.3%) |
| Mar 2011 | - | $3.42 M(+0.5%) | $13.41 M(+1.3%) |
| Dec 2010 | $13.23 M(+4.4%) | $3.40 M(+1.8%) | $13.23 M(+1.1%) |
| Sept 2010 | - | $3.34 M(+2.4%) | $13.09 M(+1.2%) |
| June 2010 | - | $3.26 M(+0.7%) | $12.93 M(+0.8%) |
| Mar 2010 | - | $3.24 M(-0.4%) | $12.83 M(+1.2%) |
| Dec 2009 | $12.67 M(+7.3%) | $3.25 M(+2.1%) | $12.67 M(+2.8%) |
| Sept 2009 | - | $3.19 M(+1.0%) | $12.33 M(+0.8%) |
| June 2009 | - | $3.15 M(+2.4%) | $12.23 M(+2.0%) |
| Mar 2009 | - | $3.08 M(+5.9%) | $11.99 M(+1.5%) |
| Dec 2008 | $11.81 M | $2.91 M(-5.6%) | $11.81 M(+32.7%) |
| Sept 2008 | - | $3.08 M(+5.6%) | $8.90 M(+53.0%) |
| June 2008 | - | $2.92 M(+0.7%) | $5.82 M(+100.7%) |
| Mar 2008 | - | $2.90 M | $2.90 M |
FAQ
- What is Ionis Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual interest expense year-on-year change?
- What is Ionis Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly interest expense year-on-year change?
- What is Ionis Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM interest expense year-on-year change?
What is Ionis Pharmaceuticals annual interest expense?
The current annual interest expense of IONS is $75.60 M
What is the all time high annual interest expense for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual interest expense is $75.60 M
What is Ionis Pharmaceuticals annual interest expense year-on-year change?
Over the past year, IONS annual interest expense has changed by +$72.80 M (+2599.89%)
What is Ionis Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of IONS is $21.23 M
What is the all time high quarterly interest expense for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly interest expense is $22.79 M
What is Ionis Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, IONS quarterly interest expense has changed by +$854.00 K (+4.19%)
What is Ionis Pharmaceuticals TTM interest expense?
The current TTM interest expense of IONS is $85.43 M
What is the all time high TTM interest expense for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM interest expense is $85.43 M
What is Ionis Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, IONS TTM interest expense has changed by +$28.88 M (+51.07%)